35.1 C
Saturday, July 20, 2024

Torrent Pharma receives EIR from US FDA for Dahej facility


Share post:


Mumbai: Pharma major, Torrent pharma on Thursday said the US drug regulator US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (EIR) for the company’s manufacturing facility at Dahej, Gujarat, and that the inspection has now been successfully closed by the US FDA.

Based on the March 2019 Inspection outcome, the Dahej facility was placed under “Official Action Indicated (OAI)” by the US FDA. The drug regulator had conducted re-inspection of the site in May 2023 from May 17, 23 to May 25, 23 and issued Form 483 with 2 observations.

The updated classification of site is VAI (voluntary action indicated) which indicates that Torrent will start to get approval of filed ANDAs. This will further enhance the company’s prospects and foster growth in the US market with its new product offerings.

The Dahej facility manufactures APIs and formulations for Torrent Pharma’s international markets.

Related articles

Arunachal Pradesh Chief Minister Prema Khandu lauds contribution of Catholic missionaries to society

Bharatiya Janata Party leader and the chief minister of Arunachal Pradesh, Prema Khandu, lauded a group of Catholic...

Israel rejects advisory opinion of ICJ on Israel-Palestine conflict

In an official statement released by the Ministry of Foreign Affairs, Israel, the advisory opinion issued by the...

Amit Shah chairs high-level meeting to review functioning of Multi Agency Centre (MAC) of IB

Union Home Minister Amit Shah chaired a high-level meeting on Friday, July 19, with various heads of security...

Goa’s Parallel Universe: Sarpanch Dr Pramod Sawant and Waiter Yuri Alemao

In a whimsical twist of fate, the vibrant and politically charged state of Goa finds itself caught in...